NCT05102799View on ClinicalTrials.gov

MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

February 1, 2026

Study Completion Date

August 1, 2026

Conditions

Limb Girdle Muscular Dystrophy

Interventions

OTHER

No intervention

No intervention

Trial Locations (1)

2100

RECRUITING

Nanna Scharff Poulsen, Copenhagen

All Listed Sponsors

lead

Rigshospitalet, Denmark

OTHER